# National Trial of CGM in Pregnant Women With Type 2 Diabetes

Study · id `cardio:ct-nct06903728` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06903728](<https://clinicaltrials.gov/study/NCT06903728>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06903728

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 200 participants.

## Technical summary

Registry record NCT06903728. Allocation not applicable; no masking; primary purpose treatment. Start 2026-03 (anticipated); primary completion 2026-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT06903728, source copy `cardio:ctgov-nct06903728-2025-07-31`, retrieved 2026-10-26)
- Planned start: 2026-03 (anticipated) (ClinicalTrials.gov record NCT06903728, source copy `cardio:ctgov-nct06903728-2025-07-31`, retrieved 2026-10-26)
- Primary completion: 2026-12 (anticipated) (ClinicalTrials.gov record NCT06903728, source copy `cardio:ctgov-nct06903728-2025-07-31`, retrieved 2026-10-26)
- Completion: 2026-12 (anticipated) (ClinicalTrials.gov record NCT06903728, source copy `cardio:ctgov-nct06903728-2025-07-31`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06903728-2025-07-31`, retrieved 2026-10-26)

## The registry's words

- Brief title: National Trial of CGM in Pregnant Women With Type 2 Diabetes
- Condition: Type 2 Diabetes
- Condition: Pregnancy
- Intervention (Device): continous glucose monitoring
- Lead sponsor: Odense University Hospital
- Lead sponsor class: OTHER
- Collaborator: Steno Diabetes Center Odense
- Collaborator class: OTHER
- Collaborator: Steno Diabetes Center Copenhagen
- Collaborator class: OTHER
- Collaborator: Aarhus University Hospital
- Collaborator class: OTHER
- Collaborator: Steno Diabetes Center Nordjylland
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Odense University Hospital (`cardio:org-odense-university-hospital`)
- Registry lists this organization as a collaborator: Steno Diabetes Center Odense (`cardio:org-steno-diabetes-center-odense`)
- Registry lists this organization as a collaborator: Steno Diabetes Center Copenhagen (`cardio:org-steno-diabetes-center-copenhagen`)
- Registry lists this organization as a collaborator: Aarhus University Hospital (`cardio:org-aarhus-university-hospital`)
- Registry lists this organization as a collaborator: Steno Diabetes Center Nordjylland (`cardio:org-steno-diabetes-center-nordjylland`)

## Provenance

Content hash: 414edfaf040023536a04779a0425d0f21bc667ecb88bd3a9c39c98535581c6a3
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
